ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 20 filers reported holding ENZYMOTEC LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $22,000 | -12.0% | 1,935 | -37.0% | 0.00% | – |
| Q2 2017 | $25,000 | +525.0% | 3,071 | +514.2% | 0.00% | – |
| Q1 2017 | $4,000 | -63.6% | 500 | -71.3% | 0.00% | – |
| Q4 2016 | $11,000 | -38.9% | 1,743 | -29.3% | 0.00% | – |
| Q3 2016 | $18,000 | +125.0% | 2,467 | +154.3% | 0.00% | – |
| Q2 2016 | $8,000 | +166.7% | 970 | +160.8% | 0.00% | – |
| Q1 2016 | $3,000 | -82.4% | 372 | -78.8% | 0.00% | – |
| Q4 2015 | $17,000 | -69.6% | 1,756 | -71.6% | 0.00% | – |
| Q3 2015 | $56,000 | +55.6% | 6,194 | +44.9% | 0.00% | – |
| Q2 2015 | $36,000 | +2.9% | 4,275 | -10.4% | 0.00% | – |
| Q1 2015 | $35,000 | -14.6% | 4,770 | -11.6% | 0.00% | – |
| Q4 2014 | $41,000 | – | 5,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 202,962 | $5,482,000 | 1.66% |
| Visium Asset Management, LP | 690,000 | $18,637,000 | 0.37% |
| ALYDAR PARTNERS LLC | 90,000 | $2,431,000 | 0.25% |
| Paulson & Co. | 1,733,030 | $46,809,000 | 0.23% |
| GILDER GAGNON HOWE & CO LLC | 218,232 | $5,894,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 83,971 | $2,268,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 10,000 | $270,000 | 0.04% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 5,450 | $148,000 | 0.03% |
| TFS CAPITAL LLC | 9,736 | $263,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 208,806 | $5,640,000 | 0.01% |